University of Missouri School of Medicine MU Health School of Medicine
News Divider
            


World Ophthalmology Congress Brings MU Discoveries Into Focus


Nanomedicine research could help millions suffering from corneal conditions

Mohan
Rajiv Mohan, PhD
A University of Missouri research program that examines how nanotechnology could treat corneal diseases will be featured at the 2010 World Ophthalmology Congress from June 5 to June 9, 2010. Rajiv Mohan, PhD, associate professor of ophthalmology at the MU School of Medicine, will present how nanoparticles could be paired with therapeutic genes to deliver new treatments to corneal tissue. The promising new therapy could help millions who suffer from corneal scarring, wounds and other conditions.

Mohan was one of only five basic scientists invited to make a presentation at the nanotechnology session of the meeting, which will draw more than 6,000 attendees to Berlin.

"Because the meeting is primarily for physicians to discuss clinical care, basic science research that is presented must be able to translate from the bench to the bedside," Mohan said. "This selection is a direct reflection of MU's commitment to translational research in ophthalmology and to discoveries campuswide."

The cornea is the dome-shaped surface that functions as the eye's outermost layer. It is the first line of defense in shielding the eye from injury as well as infections. Corneal haze, scarring and abnormal blood vessel development are among the leading causes of vision impairment in the world and affect approximately 1.5 million Americans every year. Abnormal wound healing due to corneal injury or infection has been shown to play a critical role in causing these and other corneal disorders and diseases.

Mohan's laboratory is researching how hybrid gold nanoparticles and biodegradable polymeric nanoparticles can be used as a nonviral carrier to deliver gene therapy to the cornea. The nanoparticle-based gene therapy has shown minimal side effects in preclinical studies.

"The current nonviral vectors, or gene delivery vehicles, are incapable of delivering therapeutic levels of genes into the cells of the cornea," Mohan said. "Nanoparticles, because they are smaller, could provide a less invasive option for delivering the gene therapy effectively while reducing the risk of infection and side effects from treatment."

Mohan's corneal gene therapy research is funded by more than $2.8 million in grants from the National Eye Institute and Department of Veterans Affairs. The Association for Research in Vision and Ophthalmology recently identified findings from his laboratory as among the "the newest and most innovative" in the field of nanotechnology for drug and gene delivery.

The World Ophthalmology Congress brings together ophthalmologists to enhance education and improve access to the highest quality eye care. More information about its efforts to preserve and restore vision is available at http://www.icoph.org/advancing_leadership/ico_commitments_programs.html


Missouri Health News Network

Divider

News and Events

Binge Drinking MU Researchers Identify Epigenetic Changes Caused by Binge Drinking
Overconsumption of alcohol triggers inflammatory response in the liver

Coulter MU Awards Grants to Advance Biomedical Discoveries
Coulter program pairs physicians, engineers to develop new health technologies

Dermatology Gala Gala To Celebrate Five Decades Of Dermatology At MU
Dermatology residency program began in 1963

HIV MU Researchers Discover Protein's Ability To Inhibit HIV Release
TIM-family proteins also play role in Ebola and other viral infections

McAndrew $2.4 Million Gift Funds Endowed Chair in Cancer Research
Support inspired by experience with cancer center and student at MU

Lai MU Researchers Find Gene Therapy Protects Mice from Heart Condition
The condition is a leading cause of death for those with Duchenne muscular dystrophy

White Coat Ceremony MU's Expanded Medical Class Receives White Coats at Ceremony
Event marks start of professional journey for 104 students

Belden Interactive E-Book Aims to Improve Electronic Health Records
E-book provides guidelines for usability of EHRs

Delafontaine Tulane Cardiovascular Researcher Named School of Medicine Dean
Patrice Delafontaine, MD, is accomplished physician-scientist, educator, administrator

Frederick Fraunfelder, MD Fraunfelder Joins MU School of Medicine as Chair of Ophthalmology
Fraunfelder specializes in corneal disease, cancers of the eye and laser surgery

Karl D. Nolph, MD In Memoriam: Karl D. Nolph, MD
Nephrology leader was pioneer in the field of dialysis




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Rich Gleba
glebar@health.missouri.edu
(573) 884-0298

Laura Gerding, APR
gerdingla@health.missouri.edu
(573) 882-9193

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115

Mike Muin
muinm@health.missouri.edu
(573) 884-7541



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos  
Website created and maintained by the Office of Communications.
Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2013 - The Curators of the University of Missouri System.
All rights reserved. DMCA and other copyright information. An equal opportunity/affirmative action institution.